scroll down
Global API CDMO Company
Walking with partners,
Creating value

Technology-driven gene therapy CDMO
from oligonucleotide to xRNA

View our Science & Technology

ST PHARM NEWS
ST PHARM's Participation in 2024 DCAT Week Highlights Innovation in Pharmaceutical SectorST PHARM's Participation in 2024 DCAT Week Highlights Innovation in Pharmaceutical SectorMar 20, 2024
[Notice] RNA Innovation Symposium Corea/Korea 2024 (RISC 2024)[Notice] RNA Innovation Symposium Corea/Korea 2024 (RISC 2024)Feb 26, 2024
ST PHARM, Pirmitegravir (STP0404), HIV: Three trials to watch in 2024ST PHARM, Pirmitegravir (STP0404), HIV: Three trials to watch in 2024Jan 15, 2024
Global API CDMO Company
Walking with Partners, Creating Value

30+years

Track record

40+

Global CDMO Project

6.4mole

Oligo CDMO Capacity ('22)

1.0kg / year

mRNA CDMO Capacity
Media Focus
ST PHARM Cuts Joint Research Deal with Multiverse Pharma in the U.S.Feb 24, 2023
ST PHARM, signs $9.2million contract to supply MRI contrast medium raw materialsJan 11, 2023
IR Library
Stock Information

KRWKOSDAQ

(%)

Location

70km (43 mile)

40km (25 mile)

40km (25 mile)

51km (32 mile)

Seoul Office

Seoul Office

7F, I Park Tower Bldg., Yeongdongdae-ro 520, Gangnam-gu, Seoul
06170

  • Marketing and sales
  • Regulatory affairs
  • Management

Sihwa campus

Sihwa campus

231 Hyeomnyeok-ro, Siheung-si, Gyeonggi-do
15086

  • cGMP Manufacturing
  • QC/QA
  • R&D

Banwol campus

Banwol campus

171 Haean-ro, Danwon-gu, Ansan-si, Gyeonggi-do
15610

  • cGMP Manufacturing
  • QC/QA
  • R&D

Incheon Airport

© 2024 ST Pharm. All rights reserved.